Abstract 3-Nitropropionic acid (3-NP), an inhibitor of mitochondrial complex II, leads to metabolic impairment and neurodegeneration. In this study, we investigated the roles of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the dysregulation of transcription factors and histone modifying enzymes induced by 3-NP in primary cortical neurons. BDNF prevented the 3-NPinduced decrease in cAMP response-element binding protein (CREB) phosphorylation and CREB-binding protein levels. Both NGF and BDNF counteracted the increase in the levels of histone H3 and H4 acetylations and reduced histone deacetylase (HDAC) activity induced by 3-NP. BDNF further led to hyperphosphorylation of HDAC2. Our results support an important role for neurotrophins, particularly BDNF, in preventing detrimental changes in transcription factors and histone acetylation states in cortical neurons that have been subjected to selective mitochondrial inhibition.
Introduction 3-Nitropropionic acid (3-NP) is an irreversible inhibitor of succinate dehydrogenase, an enzyme involved in both the tricarboxylic acid cycle and complex II of the electron transport chain (Coles et al. 1979; Huang et al. 2006) . Chronic administration of 3-NP causes prolonged energy impairment and leads to a pattern of neurodegeneration similar to that seen in Huntington's disease (Beal et al. 1993; Gu et al. 1996; Brouillet et al. 1998) . The mechanism of 3-NP-induced neurotoxicity has been shown to involve depletion of ATP, mitochondrial membrane depolarization, accumulation of intracellular Ca 2? , excessive mitochondrial reactive oxygen species production, and activation of caspases and calpains (Lee et al. 2002; Bizat et al. 2003; Almeida et al. 2004 Almeida et al. , 2006 . Effects on gene expression have also been demonstrated to play a role in 3-NP-induced toxicity. These alterations appear to occur at the level of specific chromatin modifications, and are an aspect of 3-NP-induced cell death that have not been completely elucidated. Indeed, recent data have shown that apoptosis is accompanied by global changes in histone modifications such as phosphorylation or ubiquitination (Mimnaugh et al. 2001; Talasz et al. 2002) and the activity of many proteins that modify histones is often affected by caspase-mediated cleavage (Casciola-Rosen et al. 1995; Smith et al. 1999 ).
Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) are members of the neurotrophin family that have been implicated in the regulation of development, and adult synaptic, and neuronal survival (Lu et al. 2005) . The effects of these neurotrophins are mediated by Trk receptor-induced activation of key signaling pathways including PLC-c, Ras/MEK/MAPK, and PI3K/Akt. Signaling culminates in the transcription of neuroprotective proteins through the activation of critical transcription factors such as cAMP response-element binding protein (CREB) and nuclear factor-jB (NFjB, Huang and Reichardt 2003) . When activated by phosphorylation, CREB binds to its co-activator CREB-binding protein (CBP) and the complex is competent to initiate gene transcription (Mayr and Montminy 2001) . Similarly, phosphorylation of IjB releases the p65:p50 NFjB heterodimers, which then translocate to the nucleus to initiate transcription. Pro-survival proteins whose expression is dependent on these transcription factors include such proteins as Bcl-2, manganese superoxide dismutase, and BDNF (Saha and Pahan 2006) .
In this study, we analyzed the influence of BDNF and NGF on 3-NP-mediated toxicity and its effects on transcription factors, namely CREB, CBP, and NFjB. These transcription factors are involved in the expression of protective proteins, as well as in the acetylation state of histones in cortical neurons. This study may help to determine the role of these transcription factors in neurotrophin-mediated neuroprotection against toxic effects due to mitochondrial dysfunction.
Materials and Methods

Materials
Neurobasal medium and B-27 supplement were purchased from GIBCO (Paisley, UK). 3-NP was from Sigma Chemical Co. (St. Louis, MO, USA). N-acetyl-Asp-GluVal-Asp-p-nitroanilide (Ac-DEVD-pNA) was obtained from Calbiochem (Darmstadt, Germany). BDNF and NGF were from Alomone Labs (Jerusalem, Israel). All other reagents were of analytical grade.
Cell Culture
Rat primary cortical neurons were prepared as previously described (Almeida et al. 2004) . In brief, cerebral cortices were dissected from 16-to 17-day-old fetal rats of the Wistar strain and the cells were dissociated. Cortical neurons were resuspended in Neurobasal medium supplemented with 2% B-27, 0.2 mM glutamine, 100 U/ml penicillin, and 0.1 mg/ml streptomycin and cultured in a humidified incubator at 37°C, 5% CO 2 . After 6 days, neurons were pretreated with BDNF (100 ng/ml) or NGF (100 ng/ml) for 30 min, and then incubated with 0.3 mM 3-NP for 24 h. This 3-NP concentration induces apoptotic processes and does not have necrotic characteristics (Almeida et al. 2004) . The 3-NP stock solution was prepared in water and brought to pH 7.4 with NaOH.
Subcellular Fractionation
Total Cell Lysate
Cells were washed twice in ice-cold PBS and resuspended in lysis buffer [20 mM Tris (pH 7.0), 100 mM NaCl, 2 mM EDTA, 2 mM EGTA, 1% Triton X-100] supplemented with 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM 1,4-dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF), and 1 lg/ml protease inhibitor cocktail (chymostatin, pepstatin A, leupeptin, and antipain). The lysates were sonicated on ice for 30 s and centrifuged (14,000 rpm for 10 min, Eppendorf Centrifuge 5417R) to remove insoluble material. The supernatants were collected, assayed for protein content using the Bio-Rad reagent according to manufacturer's instructions, and stored at -80°C.
Nuclear Extracts
Nuclear extracts were obtained using a previously described protocol (Santos et al. 2001) . In brief, cells were washed twice in ice-cold PBS, resuspended in buffer A (10 mM HEPES, 10 mM NaCl, 3 mM MgCl 2 , 1 mM EGTA, 0.1% Triton X-100, pH 7.5) supplemented with 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM DTT, 1 mM PMSF, and 1 lg/ml protease inhibitor cocktail and incubated on ice for 40 min. The nuclei were pelleted by centrifugation at 24009g for 10 min at 4°C and resuspended in buffer B (25 mM HEPES, 300 mM NaCl, 5 mM MgCl 2 , 1 mM EGTA, 20% glycerol, pH 7.4) supplemented with 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM DTT, 1 mM PMSF, and 1 lg/ml protease inhibitor cocktail. After incubation on ice for 60 min, the lysates were centrifuged at 12,0009g for 20 min at 4°C. The supernatants (nuclear extracts) were collected, assayed for protein content using the Bio-Rad reagent, and stored at -80°C.
Immunoprecipitation Assay
Total cell lysates (700 lg protein) were precleaned with protein A-Sepharose (Amersham Biosciences, Buckinghamshire, UK) at 4°C for 1 h, and the supernatants were then incubated with a rabbit anti-HDAC2 antibody (Abcam, Cambridge, UK, 1:100) on a rotary mixer overnight at 4°C. 50 ll of protein A-Sepharose was added to the immune complexes and tubes were incubated for an additional of 2 h at 4°C. Immune complexes were isolated by centrifugation and washed twice with 1 ml of lysis buffer, thrice with lysis buffer plus 500 mM NaCl, and twice with lysis buffer without Triton X-100. The total immunoprecipitated sample was loaded on the gel.
Western Blotting Analysis
Fifty (total cell lysate) or 35 lg (nuclear extract) of protein was separated on SDS-PAGE gels and transferred to polyvinylidene difluoride membranes. After blocking with 5% non-fat milk in TBS (25 mM Tris/HCl, pH 7.6, 150 mM NaCl)/0.1% Tween, for 2 h at room temperature, the membranes were incubated with antibodies directed against CBP (Cell Signaling, Danvers, MA, USA, 1:1,000), a-tubulin (Sigma, 1:30,000), phospho-CREB (P-CREB) (Cell Signaling, 1:500), CREB (Cell Signaling, 1:750), NFjB p65 (Cell Signaling, 1:500), phospho-serine (P-Ser) (Abcam, 1:200), H3 (Upstate, Lake Placid, NY, USA, 1:500), H4 (Upstate, 1:30,000), Acetyl-H3 (Upstate, 1:20,000), or Acetyl-H4 (Upstate, 1:750) overnight, at 4°C. The membranes were further incubated with the secondary antibody for 2 h at room temperature and the proteins were visualized using an enhanced chemifluorescence reagent (Amersham Biosciences).
Caspase Protease Activity Assay Caspase-like activity was determined as described previously (Almeida et al. 2004 ). In brief, cortical cells were lysed and centrifuged at 14,000 rpm (Eppendorf Centrifuge 5417R) for 10 min. The resulting supernatants were collected and assayed for protein content using the Bio-Rad reagent, according to manufacture's instructions. Caspase-3-like activity was measured using Ac-DEVD-pNA as substrate. Caspase-like activity was calculated as the increase above the control, for equal protein loading (25 lg).
Histone Deacetylase Activity
Histone deacetylase (HDAC) activity was measured with the Colorimetric HDAC Activity Assay Kit (BioVision, CA, USA) according to manufacturer's instructions. In brief, nuclear extracts were incubated with the HDAC substrate Boc-Lys(Ac)-pNA (10 mM) in HDAC assay buffer. After 90 min at 37°C, reactions were stopped by adding 10 ll of Lysine Developer and further incubated for 30 min at 37°C. Absorbance was measured at 405 nm using a 96-well plate reader (SPECTRA max plus 384, Molecular Devices, Sunnyvale, CA, USA). HDAC activity is presented as the percentage of control (untreated cells). HeLa cell nuclear extracts served as a positive control.
Histone Acetyltransferase Activity
Histone acetyltransferase (HAT) activity was measured using the colorimetric HAT activity assay kit (Abcam) according to manufacturer's instructions. In brief, nuclear extracts (10 lg) were incubated with HAT substrates I and II and NADH generating enzyme in HAT assay buffer, for 4 h at 37°C. Absorbance was measured at 440 nm using a microplate reader (SPECTRA max plus 384, Molecular Devices). HAT activity is presented as the percentage of control (untreated cells). Nuclear extracts provided by the manufacturer were used as a positive control.
Statistical Analysis
Data were expressed as mean ± SEM of the number of experiments indicated in the figure legends. Comparisons among multiple groups were performed with one-way analysis of variance (ANOVA) followed by the TukeyKramer post-hoc test. Significance was defined as P \ 0.05.
Results
We have previously shown that treatment of cortical neurons with 3-NP leads to the activation of mitochondrialdependent apoptotic cell death (Almeida et al. 2004) . The activation of caspase-3, a well-known mediator of cell death, is reduced by approximately 29% (P \ 0.05) and 25% (P \ 0.05) when cortical neurons are treated with NGF (100 ng/ml) or BDNF (100 ng/ml), respectively, prior to 3-NP (0.3 mM) addition (Table 1) . Therefore, we explored the effect of these neurotrophins on the 3-NPinduced dysregulation of transcription factors that promote the expression of protective proteins. As shown in Fig. 1a , 3-NP decreased the levels of the co-activator CBP by approximately 60% (P \ 0.05). Similarly, CREB phosphorylation on Ser133 was decreased by approximately 33% (P \ 0.05) (Fig. 1b) , suggesting a decrease in activated CREB in response to 3-NP. BDNF (100 ng/ml), but not NGF (100 ng/ml), restored both CBP and CREB phosphorylation levels. Interestingly, BDNF treatment in the absence of 3-NP also increased CBP levels (Fig. 1a) . In contrast, the levels of the NFjB p65 subunit in nuclear extracts were not affected by 3-NP, NGF, or BDNF treatment (Fig. 1c) , indicating that this transcription factor is neither involved in the detrimental effects of 3-NP nor the protective effects of NGF or BDNF.
Given that CBP has acetyltransferase activity (Kalkhoven et al. 2002) , we examined the acetylation state of histones H3 and H4 (Fig. 2a, b ) in response to 3-NP exposure. Despite reduced CBP levels, addition of 3-NP greatly increased the acetylation levels of both H3 (177%, P \ 0.001) and H4 (260%, P \ 0.001). This result suggested that acetylation of histones H3 and H4 in response to 3-NP addition is independent of the levels of CBP. We therefore determined the overall activity of HATs and HDACs in our system. We found that HAT activity did not change in response to 3-NP addition, or upon incubation with NGF or BDNF (Fig. 2c) . However, 3-NP significantly decreased HDAC activity by about 20% (P \ 0.001; Fig. 2d ) suggesting that the increase in histone acetylation levels observed in response to 3-NP is due to a decrease in HDAC activity with no detectable alteration in HAT Neurotox Res (2010) 17:399-405 401 activity. In addition, both NGF and BDNF counteracted the decrease in HDAC activity caused by 3-NP exposure (Fig. 2d) . Previously, HDAC1 and HDAC2 were shown to become hyperphosphorylated in response to inhibition of protein phosphatases by okadaic acid, and this hyperphosphorylation results in increased deacetylase activity (Galasinski et al. 2002) . We therefore tested whether NGF and BDNF treatment affected HDAC2 phosphorylation levels. HDAC2 was immunoprecipitated from control, NGF/ BDNF, 3-NP, or NGF/BDNF plus 3-NP-treated cells, and phosphorylation of HDAC2 was detected with a P-Ser antibody. Our results show that HDAC2 is phosphorylated under basal conditions in untreated neurons, similar to K562 human erythroleukemia cells (Galasinski et al. 2002) . Exposure to 3-NP did not affect P-Ser-HDAC2 levels. However, BDNF treatment leads to hyperphosphorylated HDAC2 after a 24-h incubation whether or not 3-NP was present (Fig. 2e) . Similar experiments were attempted for HDAC1, but we were not able to detect phospho-HDAC1, most likely because the anti-HDAC1 antibody did not work very well in the immunoprecipitation assay.
Discussion
Here we show that both NGF and BDNF reduce the acetylation of histones H3 and H4 that likely results from reduced HDAC activity caused by 3-NP. In contrast, only BDNF is able to prevent the reduced CREB phosphorylation and CBP levels induced by 3-NP, and BDNF treatment alone results in hyperphosphorylated (activated) HDAC2. Cortical neurons were pre-treated with NGF (100 ng/ml) or BDNF (100 ng/ml) for 30 min and further incubated in the absence or presence of 0.3 mM 3-NP for 24 h. Caspase-3-like activity was measured by following the cleavage of the colorimetric substrate Ac-DEVD-pNA and its activity expressed as the increase in optical density values above the control (untreated neurons). Results were expressed as the mean ± SEM of five distinct experiments. Statistical analysis: *** P\0.001, compared to untreated neurons; # P\0.05, compared to 3-NP-treated neurons in the absence of NGF or BDNF Fig. 1 BDNF prevents the 3-NP-induced decreases in CREB activation and CBP levels. Total cell lysates (a) and nuclear extracts (b, c) were analyzed by Western blotting for CBP (a), phospho-CREB (b), and NFjB p65 (c). Blots show a representative experiment from four to six independent experiments producing similar results. Graphs show densitometric analysis performed by normalizing phosphorylated protein signal to the respective total protein band, CREB (a nuclear protein) or a-tubulin (a-Tub). Data are the mean ± SEM of four to six independent experiments. Statistical analysis: * P \ 0.05, compared to untreated neurons; # P \ 0.05, compared to 3-NPtreated neurons in the absence of NGF or BDNF CREB is a widely expressed transcription factor whose role in neuronal protection is well established. The phosphorylation status of CREB is critical for its activity, and several protein kinases, such as calcium/calmodulindependent kinase II and IV, protein kinase C, PI3K, Akt, MAPK, and Rsk2, have been reported to promote the activation of CREB (Yamamoto et al. 1988; Matthews et al. 1994; Du and Montminy 1998; Bito et al. 1996; Impey et al. 1998; Perkinton et al. 2002) . Phosphorylation on Ser133 leads to CREB activation and, via interaction with its nuclear partner CBP, promotes the transcription of a large number of genes (Mayr and Montminy 2001) . Our results show that 3-NP treatment of cortical neurons decreases both CREB phosphorylation on Ser133 and CBP levels, strongly suggesting reduced CREB-dependent gene expression/ activation. One possible explanation for the decreased CREB phosphorylation would be the activation of phosphatases in response to 3-NP exposure. Several studies have Fig. 2 Effects of NGF and BDNF on histone acetylation in response to 3-NP treatment. Nuclear extracts (a-d) and total cell lysates (e) were analyzed for acetyl-H3 and H3 (a), acetyl-H4 and H4 (b), HAT activity (c), HDAC activity (d), and P-Ser-HDAC2 (e). a, b Blots show a representative experiment from four to six independent experiments producing similar results. Graphs show densitometric analysis performed by normalizing acetylated protein signal to the respective total protein band. c, d HAT/HDAC activity is represented as a percentage of control (untreated neurons). Data are the mean ± SEM of three to seven independent experiments. e HDAC2 was immunoprecipitated and the phosphorylated and hyperphosphorylated forms were detected with an anti-phosphoserine antibody. Shown is a representative blot from three independent experiments producing similar results, and the graph shows the densitometric analysis of the phosphorylated and hyperphosphorylated forms of HDAC2. The lower band seen in the blot (*) is cross-reactive IgG (*50 kDa) and was used as a loading control. Statistical analysis: * P \ 0.05, *** P \ 0.001, compared to untreated neurons; # P \ 0.05, ## P \ 0.01, ### P \ 0.001, compared to 3-NP treated neurons in the absence of NGF or BDNF Neurotox Res (2010) 17:399-405 403 shown that protein phosphatase 2B and calcineurin, whose expression is regulated by 3-NP (Napolitano et al. 2004) , also regulate the duration of CREB phosphorylation (Bito et al. 1996; Liu and Graybiel 1996; Wu et al. 2001) . However, the concentration of 3-NP used in this study did not significantly alter calcineurin (Almeida et al. 2004) or protein phosphatase 2A (data not shown) activities. The effect of 3-NP on CREB phosphorylation was reversed by BDNF, most likely due to sustained activation of the PI3K/ Akt, the Ras/MAPK, or both kinase pathways, as we have recently demonstrated (Almeida et al. 2009 ).
The decrease in total CBP levels after 3-NP exposure may be explained by an independent mechanism. CBP has previously been reported to be specifically targeted for cleavage by caspases and calpains at the onset of neuronal apoptosis (Rouaux et al. 2003) . Thus, under our experimental conditions, the decrease in CBP could be due to caspase-3, but not calpain activation (Almeida et al. 2004) . Indeed, BDNF addition reduces both caspase-3 activation and the decrease in CBP caused by 3-NP. Nevertheless, although NGF can reduce 3-NP-induced caspase-3 activation, it did not block the decrease in CBP levels caused by 3-NP, suggesting an alternative mode of regulation for CBP levels may also be involved.
In previous studies, Rouaux et al. (2003) reported that a decrease in CBP was correlated with the reduced acetylation of histones H3 and H4, and with a reduction in CBP/ p300 HAT activity, even while total HAT activity remained unchanged. Similarly, we found that 3-NP did not alter total HAT activity, but significantly decreased overall HDAC activity, likely explaining why we did not observe a reduction in H3 or H4 acetylation. Instead, we observe an increase in both H3 and H4 acetylation in cortical neurons upon exposure to 3-NP. Because 3-NP induces caspase-3 activation (Almeida et al. 2004 and Table 1 ), we hypothesize that caspase-3 plays a role in inactivating HDACs. Conversely, decreased caspase activation induced by both BDNF and NGF treatment could be the mechanism by which the neurotrophins rescue HDAC inhibition and the resultant increase in H3/H4 acetylation caused by 3-NP. Accordingly, caspase-3 and the mitochondrial pathway have been shown to be critical in triggering HDAC4 processing after a genotoxic stress (Paroni et al. 2004) . Other studies have shown that HDAC3 is cleaved in a caspase-dependent manner after the onset of apoptosis (Panteleeva et al. 2004; Escaffit et al. 2007 ). However, these authors neither observe changes in overall HDAC activity when nuclear extracts were incubated with caspase-3 (Paroni et al. 2004 ) nor find any increase in H3 and H4 acetylation following the induction of apoptosis (Escaffit et al. 2007 ). Therefore, 3-NP may also inhibit HDAC activity through additional mechanisms distinct from apoptosis.
Another possible mechanism for BDNF and NGF modulation of HDACs is that they can be regulated by phosphorylation (Saha and Pahan 2006) . HDAC1, HDAC2, and HDAC3 are phosphorylated by a distinct set of kinases, leading to their assembly into repressive complexes that show enhanced enzymatic activity and cause inhibition of gene expression (Saha and Pahan 2006) . BDNF and NGF may restore HDAC activity reduced by exposure to 3-NP by positive regulation of the kinases involved in the activation of HDACs. We found that BDNF treatment enhanced HDAC2 phosphorylation, a post-translational modification that has previously been reported to be associated with an increase in deacetylase activity (Galasinski et al. 2002) . In contrast, we were unable to detect any increase in HDAC2 phosphorylation after NGF treatment, possibly because NGF is not able to continuously activate the PI3K/Akt and/or Ras/MAPK pathways as BDNF does (Almeida et al. 2009 and unpublished data) . NGF protection may thus involve a distinct mechanism. Although the increase in HDAC2 phosphorylation by itself may not be sufficient to change overall HDAC activity, we cannot exclude the possibility that alterations in other HDACs may be occurring. Furthermore, it provides a possible mechanism by which neurotrophins, and in particular BDNF, can regulate HDAC activity and possibly gene expression.
In summary, our data suggest that BDNF and NGF induce positive changes in the levels and activities of transcription factors involved in cell survival. In addition, both neurotrophins counteract chromatin-bound histone acetylation modifications that result upon mitochondrial inhibition. These effects likely explain the neuroprotective role of these neurotrophins in the context of mitochondrial dysfunction.
